Enhancer-associated RNAs as therapeutic targets

Area of Science:

• Molecular Biology
• Epigenetics
• Genomics

Background:

• Gene expression is tightly regulated by complex networks involving cis-acting and trans-acting elements.
• Enhancer RNA (eRNA)-producing domains are emerging as critical regulators of transcription and cellular decisions.
• Dysregulation of eRNAs is increasingly linked to various human diseases.

Purpose of the Study:

• To review the mechanisms of eRNA-producing domain selection and activation.
• To explore the epigenetic features and functions of eRNAs.
• To discuss the therapeutic potential of targeting eRNAs.

Main Methods:

• Review of current literature on eRNA-producing domains.
• Analysis of mechanisms controlling eRNA expression.
• Examination of the role of eRNAs in disease pathogenesis.

Main Results:

• eRNA-producing domains are selected and activated in a cell-type-specific manner.
• Epigenetic modifications play a crucial role in regulating eRNA production.
• eRNAs are implicated in the deregulation observed in several human diseases.

Conclusions:

• eRNAs are key regulators of transcription with significant therapeutic potential.
• Targeting eRNAs presents a novel avenue for developing new therapies.
• Further research and genetic tools are necessary to fully realize the clinical applications of eRNA-based therapies.